@whistlebower99.

1. Unusual item - @ Note A5 on page 11.

2. The Group reported a profit before tax of RM35.41 ... - @ Note B2 on page 17.

------------------------------

You are not so keen to read the financial statements and its notes fully.

@whistlebower99.
I have posted it @ my earlier posting in this thread.

YOU HAVE TO READ IT, IF NOT THE NOTES GIVEN IN 4QR 2021 IS JUST LIKE A THRASH.

-------------

MZM2511 Unusual Items
During the quarter under review, the Company had on 10 May 2021 announced that Borneo
Energy Sdn Bhd, its indirect wholly-owned subsidiary, had entered into a Sale and Purchase
Agreement with Gold Billion Global Limited (BVI Company No. 1759774), a wholly-owned
subsidiary of Verde Resources Inc., a Nevada USA corporation listed under OTCQB for the
disposal of Technology Assets and Intellectual Property Rights for a total consideration of USD5
million to be fully settled by way of allotment of shares in Verde Resources Inc. The shares in
Verde Resources Inc. had been reflected as an investment in quoted securities and fair value
through profit and loss accordingly in the quarter under review
30/08/2021 7:32 PM


MZM2511 @todak_ensem

The Group reported a profit before tax of RM35.41 million compared to a loss before tax of
RM3.61 million mainly due to the fair value gain on investment in quoted securities of RM26.46
million, reversal of impairment loss of RM18.63 million and disposal of business assets of
RM1.91 million
30/08/2021 7:34 PM

BilisMasin My comment

All is just on paper. The fact is, RM 0.045
----------------

We are facing future, not yesterday. You can have your own stand. I also have mine.
As investing is full of risks. I am prepared to fail because relying on the said RI theory.

------------------

I WANT TO SHARE WITH YOU MY SIMPLE THEORY:

But as I looked at certain companies before, after the company approved the RI and setup the issue price for RI, the share price firstly will drop.

But near the date of the RI to be executed, the price will be markup higher than the issue price of the RI.

These scenario surely not be absolutely will happen to Kanger, but it has high chance or probability to follow suit.

-----------------------------
Mr. Kuah has experienced to spearheaded corporate exercises such as fund raising, diversification and share buy-back exercises for the company.
-------------

Do you think that Mr. Kuah will let Kanger fails in the incoming RI exercises??????


We have another 10 trading days which are 1/9,2/9,3/9,6/9,7/9,8/9,9/9,10/9,13/9 and 14/9 before the last date to subscribe and pay for the right issue on 15/9.

There is enough time for the price to be cooked up.

AFTER ALL. TAYOR.

@wistlebower99.
The fact is the naysayer forever be naysayer. He He

Just look at the announcement: Red it carefully.

Source: https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3188999


Or if you hesitate to read it, just use you "buluh/buah kelapa" as your miracle mirror to guess what happen to the P&L account of Bornoil.

You can do what you did before, using those miracles to predict that "all the big NOSH company will be doing a consolidation exercises".

--------------
I'm an accountancy graduate. I can surely explain to your question about "how the accounting works". But, I can read your intention here!!!!! Just say it directly....

By the way, do you know that the "other income" thing also earned from the investment done by the company before. Therefore, the profit earned for 3QR 2021 and FY 2021 are earned from the company operations and investment.

@MrWinMoney.

It's not merely the quarterly result as it's the 4QR 2021 result.

The FY 2021 result is a positive number. Net profit around RM 28 mil for financial year 2021.

3. THE EMERGENCE OF MR KUAH CHOON CHING AS A MEMBER OF THE BOD ON 24 AUGUST 2020 AND HIS FUTURE PLAN TO BE A SUBSTANTIAL SHAREHOLDERS OF THE COMPANY

 Mr. Kuah is an experienced businessman and entrepreneur with a proven track record in the diverse sectors of consumer products, property development, and manufacturing for various packaging industries. He has experienced to spearheaded corporate exercises such as fund raising, diversification and share buy-back exercises for the company. He is very well versed in various industries, such as manufacturing and printing for the glove making, medical, electrical and electronics, automotive industries and more.
 Currently, Mr. Kuah owned 25 million units of shares, equivalent to 0.89% shareholding of the company shares, the biggest share holder amongst the member of the Board of Director of the company.
 Mr. Kuah entered into a subscription agreement for a subscription of 769.51 million new Kanger shares at the subscription price of RM0.06 per share to partially finance the purchase consideration for the acquisition of 51% stake in Sung Master. After this subscription of shares exercise, Mr. Kuah will become a substantial shareholder of Kanger.

MY COMMENTS:
a) Mr. Kuah as the Executive Chairman of the BOD has used his experiences in the company to plan some corporate exercises such as diversification and fund raising exercises for the company. The company has decided to place stronger emphasis on expanding our new business segments which are involved in construction and property investment and management. Several fund raising exercises has been planned which are involved ESOS, private placement and right issue of shares in order to fund several plans of diversification exercises.

b) As there is no substantial shareholders in the company as at 30 July 2021, the percentage of shareholdings among director and insiders is small. This condition is not so good for the company as the share holding spread in the company is too wide. Mr. Kuah will become a substantial shareholder of Kanger and will generate more positivity to the company in terms of reducing share holding spread, strengthening his BOD power in the company and uplifting his concern, ownership and integrity while managing the company.

A Glance At Positivities From The Kanger (0170) Annual Report 2021

Kanger (0170) has released the company’s Annual Report 2021. I am glad to share some positivities related to the current and future progress of the company based on my glance at the annual report. I will not take note on the balance sheets aspects in this article. The Annual Report 2021 can be retrieved @
https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3189156


Some of the positive notes are as follows:

1. NEW ENGINES OF GROWTH FOR BAMBOO AND RELATED PRODUCTS
 In the fourth quarter of 2020, the construction of the company new bamboo concession and processing plant in Jingzhou was completed. Although the plant is still in the early phases of testing and commissioning, the company is looking forward to the positive financial contribution it will bring to the Group once commercial production commences.
 The expansion in Jingzhou will allow the Group to focus not only on manufacturing of bamboo products but also processing of bamboo related foodstuff and bamboo eco-tourism in the near future.

MY COMMENT:
a) The company has stated the promising progress has been made in the relocation of our new bamboo and processing plant. The company still keen on the potentials of its bamboo and related products business to be turn around especially after the new processing plant in Jinzhou started to operate.

2. CORPORATE MILESTONES OF THE COMPANY IN 2021

 Diversified into new construction business aimed at deriving synergy with the property investment and management segment. Acquired 51% stake in building materials supplier, Sung Master Holdings Sdn Bhd for RM94.8 million. Acquired 126 units of service apartments at Antara @ Genting Highlands for RM142.87 million.

 One of the new subsidiaries, Kanger Medical International Sdn Bhd is making inroads into the healthcare industry by sourcing for face masks and Covid-19 vaccines.

MY COMMENTS:
a) These "corporate" statements give us the SIGN that the BOD and the company has tried to do some efforts for the betterment of the company in future.
b) The company are diversifying and also entering business activities in Malaysia, instead of solely relied on the PRC business activities. Some of the progress of diversification can be read below:
 Currently, the Group is working together with a few parties to complete multiple construction projects across a few sites in the state of Selangor and Pahang to the tune of approximately RM1.0 billion. The Group is also in the midst of applying for the Grade 7 contractor license from the Construction Industry Development Board (“CIDB”) and aims to tender for new construction projects to further grow our construction orderbook.
 The Group will be purchasing a 51% stake in building materials supplier, Sung Master Holdings Sdn. Bhd. The acquisition will broaden the Group’s product offerings to also include other building materials such as timber, flooring, tiles, bulk cement, concrete, locksets and sanitary ware. This strategic acquisition is well-aligned to strengthen and complement the Group’s newly established construction business as Kanger will be able to source the building materials directly from Sung Master’s suppliers to better manage the input cost and enhance the profitability of these construction projects.
 The Group had also purchased 126 service apartment units at Antara @ Genting Highlands on an enbloc basis. Expected to be completed in 2024. The company believes that the rental income or capital gains arising from these property units will contribute positively to the company.

whistlebower99 Very successful fund raising exercise

Company directors proudly and happily collected RM56,329,275 from fund raising exercise.
30/08/2021 12:04 PM

@@ Look at BCMall thread.
---------------------

If BCMall was successful in their RI exercise, therefore I think Kanger directors should have their own plans to make sure the Kanger's RI exercises also will be a success.

Apa-apa pun, TAYOR.

yaalor. We are the shareholders of Kanger. Do they the naysyers have any shares?

We as the investors are taking the risks and pray for the profit that we could earn.

By the way, still in the mode to test the theory of RI.

We have another 10 trading days which are 1/9,2/9,3/9,6/9,7/9,8/9,9/9,10/9,13/9 and 14/9 before the last date to subscribe and pay for the right issue on 15/9.

There is enough time for the price to be cooked up.

@striahijau.
------- asyik ulang dah submit, soalnya bilakah tarikh submit kepda NPRA dibuat?
---------------

Soalan ini awak boleh tanya wistlebower99. Dia memang nujum yang hebat. LEBIH HEBAT DARI NUJUM BULUH/KELAPA DIA NI.

Dia tahu, semua kaunter yang NOSH besar akan buat consolidation!!!!!. He He

In the near term, KIB targets to also commence the distribution of other healthcare-related products to expand the revenue streams under its new healthcare business.

The company has recently entered into a binding and conditional heads of agreement (HoA) with a UAE-based company to import and distribute the Hayat-Vax Covid-19 vaccines.

The Hayat-Vax vaccine is essentially the same Sinopharm Covid-19 vaccine, manufactured in UAE.

KIB has submitted the necessary applications to obtain the required approvals from the National Pharmaceutical Regulatory Agency (NPRA) for the Hayat-Vax vaccine to be used in Malaysia.


https://www.nst.com.my/business/2021/08/722649/kanger-ventures-manufacturing-sales-surgical-face-masks

Share capital 618,968, 000
Reserves 61,803,000
Retained earnings 86,720,000

@todak_ensem

The Group reported a profit before tax of RM35.41 million compared to a loss before tax of
RM3.61 million mainly due to the fair value gain on investment in quoted securities of RM26.46
million, reversal of impairment loss of RM18.63 million and disposal of business assets of
RM1.91 million

Unusual Items
During the quarter under review, the Company had on 10 May 2021 announced that Borneo
Energy Sdn Bhd, its indirect wholly-owned subsidiary, had entered into a Sale and Purchase
Agreement with Gold Billion Global Limited (BVI Company No. 1759774), a wholly-owned
subsidiary of Verde Resources Inc., a Nevada USA corporation listed under OTCQB for the
disposal of Technology Assets and Intellectual Property Rights for a total consideration of USD5
million to be fully settled by way of allotment of shares in Verde Resources Inc. The shares in
Verde Resources Inc. had been reflected as an investment in quoted securities and fair value
through profit and loss accordingly in the quarter under review

Wowww.

The prospectus for the RI.

https://www.bursamalaysia.com/market_information/equities_prices?keyword=Kanger&top_stock=top_active&board=&alphabetical=&sector=&sub_sector=

@alex.

Why so afraid of a company with billions shares?

Look at Hong Seng, it NOSH is 2.457 bil but its price is @RM1.81.
For MY E.G, its NOSH will be 8 bil + after Bonus issue. Currently, MY E.G NOSH is 3.772 bil but its share price is @RM1.89.

Therefore, the most important aspects to be look at Kanger should be the company's ability to improve its businesses, profitability and FA conditions.

If the company has a bright prospects because of exercising plans of businesses by uplifting the NOSH via right issue of shares, I think it's a good move done by the company.

Furthermore, please do not compare certain company with different management and different problem with ALMOST ALL the companies in FINTEC group...

GUYS, SORRY FOR KEEP RE POSTING THIS:

-----------------------

I WANT TO TEST MY SIMPLE THEORY OF THE RI EXERCISES ON KANGER:

But as I looked at certain companies before, after the company approved the RI and setup the issue price for RI, the share price firstly will drop.

But near the date of the RI to be executed, the price will be markup higher than the issue price of the RI.

These scenario surely not be absolutely will happen to Kanger, but it has high chance or probability to follow suit.


And:


I'm keep waiting for a good announcement from Kanger, BEFORE THE EX-DATE FOR THE RIGHT OR AT LEAST BEFORE THE ACCEPTANCE AND PAYMENT DATE FOR THE RIGHT ISSUE.

If there is any, its can be a catalyst for the price to be pushed up. The current price later should be push up to the higher level to make sure that the RI will be a success.

Take a note that the issue price for the RI share is @ 6 sen per share.>>>>>>>>>>>>>>>>>


AFTER ALL. TAYOR

@Alf13.

Q1.
As apprvl yet to obtained frm NPRA

Answer 1:

Approval from NPRA is referred to a plan to distribute Sinopharm Covid-19 vaccine. Aproved or no approval by NPRA, it does not related to other plans.

Q2.
... wud dere b likelihood the comp abort/call off d Sung Master acquisition after competed d RI exercise

Answer 2:

Those two plans has different objectives.

a. RI exercises been setup among others to be used to finance the proposed acquisition of
126 units of proposed serviced apartments located in Genting Highlands and the group's new construction business.

Source: https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3166029

b. Sung Master acquisition will be satisfied via cash, an allotment and issuance of a number of new shares to Sung Master and proposed subscription of a number of new shares by Mr Kuah Choon Ching.

Source: https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3174495

Conclusions:

1. The success of the Sinopharm Covid-19 vaccine distributorship plan will be subjected to NPRA's approval, and not related to the success of their RI exercises.

2. The failures of their RI exercises will only affect their related plans, especially the plan to acquire the proposed acquisition of Genting Highland appartments.

3. I think, as the proposed Sung Master acquisition has been approved in EGM and the sources of financing for the plan is not from the RI exercises, therefore the risks for the plan to be terminated is small.

After all, TAYOR.

@Alf13.

Q1.
As apprvl yet to obtained frm NPRA

Answer 1:

Approval from NPRA is referred to a plan to distribute Sinopharm Covid-19 vaccine. Aproved or no approval by NPRA, it does not related to other plans.

Q2.
... wud dere b likelihood the comp abort/call off d Sung Master acquisition after competed d RI exercise

Answer 2:

Those two plans has different objectives.

a. RI exercises been setup among others to be used to finance the proposed acquisition of
126 units of proposed serviced apartments located in Genting Highlands and the group's new construction business.

Source: https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3166029

b. Sung Master acquisition will be satisfied via cash, an allotment and issuance of a number of new shares to Sung Master and proposed subscription of a number of new shares by Mr Kuah Choon Ching.

Source: https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3174495

Conclusions:

1. The success of the Sinopharm Covid-19 vaccine distributorship plan will be subjected to NPRA's approval, and not related to the success of their RI exercises.

2. The failures of their RI exercises will only affect their related plans, especially the plan to acquire the proposed acquisition of Genting Highland appartments.

3. I think, as the proposed Sung Master acquisition has been approved in EGM and the sources of financing for the plan is not from the RI exercises, therefore the risks for the plan to be terminated is small.

After all, TAYOR.

GUYS, SORRY FOR KEEP RE POSTING THIS:

-----------------------

I WANT TO TEST MY SIMPLE THEORY OF THE RI EXERCISES ON KANGER:

But as I looked at certain companies before, after the company approved the RI and setup the issue price for RI, the share price firstly will drop.

But near the date of the RI to be executed, the price will be markup higher than the issue price of the RI.

These scenario surely not be absolutely will happen to Kanger, but it has high chance or probability to follow suit.


And:


I'm keep waiting for a good announcement from Kanger, BEFORE THE EX-DATE FOR THE RIGHT OR AT LEAST BEFORE THE ACCEPTANCE AND PAYMENT DATE FOR THE RIGHT ISSUE.

If there is any, its can be a catalyst for the price to be pushed up. The current price later should be push up to the higher level to make sure that the RI will be a success.

Take a note that the issue price for the RI share is @ 6 sen per share.>>>>>>>>>>>>>>>>>


AFTER ALL. TAYOR

-------- Kanger still pending approval from National Pharmaceutical Regulatory Agency (NPRA) for the import of vaccine.

Bermaksud, Kanger sepatutnya sudah buat permohonan kepada NPRA.
Adakah itu maksudnya?????

I think so. But both exercises will be done separately.

Mr Quah should subscribe this RI exercises first, as the undertakings of share subscription related to Sung Master acquisition will be executed after the RI exercises.

The Sung Master acquisition has been approved in the last EGM, but the execution of the proposed plan not yet executed.

@wistlebower99. I'm not qualified to advice on selling call or buying call in any securities transactions. He He.

@hlh1962. Yes. The new warrant also probably listed and ready for transaction on the same date.

Frankly, I will subscribe the RI shares only in a condition that the share price before the last date for acceptance and payment @ above 6 sen, for instance @ 7 sen above.

Others, maybe have different plan. TAYOR.

Trading Rights (OR) = 01 Sep 2021 - 7 Sep 2021
Last date for acceptance and payment = 15 Sep 2021 05:00 PM
Listing Date = 30 Sep 2021

whistlebower99 The company might settle for minimum subscription if the RI is under-subscribed.

-----------------
Therefore, It would be better for them to pop up the price to make sure more retailers subscribe the RI shares.

Furthermore, if the RI too much under subscribed, It's not good for the company's plan and for the overall overview of the company.

I think, they have to make sure that the RI will be a success.

TAYOR

@wistlebower99.

I still believe Kanger''s RI also will be a success.

I have a feeling that the price would be push up to more than 6 sen before the last date of subscription date.

If not, the RI I think will be a failure. If there is too much under subscription by retailers, there will be too much excess application has to be done by the substantial shareholders and directors.

TAYOR.

@nubiskubissss. You can find more if you search for it.

@nubiskubissss.

One of them. Look at some PP and RI done by Hong Seng. What is the state of Hong Seng right now. The company's price between 4.5 sen - RM1.67 (now)

https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3147350

https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3088507

https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=2991320

@whistlebower99.

I hope you also can give a list of some companies which had a successful and progressing after executed their RI exercises.

Different companies has a different management............ which we can't simply judge it before it's become a reality.

Also, how high it can be before the last date of subscription?
It's a probability. Maybe. He He

@JK22. ... Unless a very very promising good news come around before RI expire.

-------------------

Agree.

@hlh1962. If today you have 100 lots of share, on 1/9 you share account will be added with 100 lots unit of OR. If you don't want to subscribe the RI, you can try to sell the OR from 1/9 up to 7/9.
After 7/9 you can't sell the OR anymore, but you can use the OR to covert it for RI shares.
If you don't sell or convert your OR for RI shares, after 15/9/2021 your OR become toilet papers.

If you want to subscribe the RI, you can't sell the OR. You can subscribe for 100 lots of shares by paying 6 sen for each OR, you will get one unit of RI share. The last date and time for payment for acceptance of the RI shares is on 15 Sep 2021 05:00 PM.

You can refer the incoming announcement/circular by Kanger to know how to subscribe the share.

Kanger, I think is still in the operator's games. There should be operators inside this fluctuations of the share price.

Let us see what will happen, especially towards the ex-date, 27 August 2021.


I believe the company must has the plans to make sure that the company will successfully executed the RI plan.

Anyway, investing is full of risks and opportunities. TAYOR.

To do business needs capital. There are many ways to acquire the capital. Without capital there is no chance to expand the company businesses. There is a number of plans for Kanger to venture in new businesses.

The company without enough cash in its account, can generate the capital needed by exercising a debt/loan financing. The company also can generate the capital to do new investments via the issuance of new shares by exercising PP or RI. It’s not involved any major debt/loan financing facilities and it’s a ZERO RISKS FINANCING exercises .

By doing so, the company can minimize the risks of higher debt burden by the company in the future. The financing facility via issuance of new shares also could minimize the cost of financing for the company.

IF the new businesses are truly have good potential to improve the revenue and profitability of the company, I think it will be for the good to the company and it share holders.

Furthermore, my logic is, the company with plans to do something for betterment of the company is better than the company without any plans. Yes, every investment has many risks but it also maybe has many opportunities.

@Peace99. I'm not good in the chart and market transaction analysis. But I think now Kanger is probably still in the operator's games.

If there is no operators inside, I think the volume of the transaction will be not so huge as that.

Let us see what will happen, especially towards Ex-date, 27 August 2021.

@Peace99. Agree. In most cases, it's will be like that.

I believe the company must has the plans to make sure that the company will successfully executed the RI plan.

Anyway, investing is full of risks and opportunities. TAYOR.

@dchin472. ...... bosses sure always give good story but u have to think how true is the story
-----------------------
All the bosses from every listed company which have a plan for the company will announce it to give good story about their plan.

THE REALITY IS, ARE WE COMPETENT ENOUGH TO JUDGE ANY COMPANY PLANS AS VIABLE OR NOT VIABLE?

WHETHER IT'S A TRUE STORY OR NOT, WE ONLY CAN READ IT BASED ON ITS PROGRESS AND FUTURE RESULTS.

To do business needs capital. There are many ways to acquire the capital. Without capital there is no chance to expand the company businesses. There is a number of plans for Fast to venture in new businesses.

The company without enough cash in its account, can generated the capital needed by exercising a debt/loan financing. The company also can generated the capital to do new investments via the issuance of new shares by exercising PP or RI. It’s not involved any major debt/loan financing facilities and it’s a ZERO RISKS FINANCING exercises .

By doing so, the company can minimize the risks of higher debt burden by the company in the future. The financing facility via issuance of new shares also could minimize the cost of financing for the company.

If the new businesses are truly have good potential to improve the revenue and profitability of the company, I think the big NOSH issues should be no issues at all.

Furthermore, my logic is, the company with plans to do something for betterment of the company is better than the company without any plans. Yes, every investment has many risks but it also maybe has many opportunities.

@dchin.

Why so afraid of a company with 1 billion or more shares?

Look at Hong Seng, it NOSH is 2.457 bil but its price is @RM1.70. For MY E.G, its NOSH will be 8 bil + after Bonus issue. Currently, MY E.G NOSH is 3.772 bil but its share price is @RM1.96.

Therefore, the most important aspects to be look at Fast should be the company's ability to improve its businesses, profitability and FA conditions.

If the company has a bright prospects because of exercising plans of businesses by uplifting the NOSH via right issue of shares or PP, I think it's a good move done by the company.

@whistlebower99.

I WANT TO TEST MY SIMPLE THEORY OF THE RI EXERCISES ON KANGER:

But as I looked at certain companies before, after the company approved the RI and setup the issue price for RI, the share price firstly will drop.

But near the date of the RI to be executed, the price will be markup higher than the issue price of the RI.

These scenario surely not be absolutely will happen to Kanger, but it has high chance or probability to follow suit.


And:


I'm keep waiting for a good announcement from Kanger, BEFORE THE EX-DATE FOR THE RIGHT OR AT LEAST BEFORE THE ACCEPTANCE AND PAYMENT DATE FOR THE RIGHT ISSUE.

If there is any, its can be a catalyst for the price to be pushed up. The current price later should be push up to the higher level to make sure that the RI will be a success.

Take a note that the issue price for the RI share is @ 6 sen per share.>>>>>>>>>>>>>>>>>


AFTER ALL. TAYOR

wistlebower99.

I'm here safe and sound. Thank God.

@18KHarmoni. Pelabur Solution pun sudah lama menunggu Solution dapat realisasikan plan jadi pengedar vaksin Sinovac. Sudah lama dah rancangan tu dibuat. Hari ini baru sampai, confirmed.

Kalau ada rezeki tu adalah nanti. Kalau langsung tak ada, memang con lah Kanger. He He

SORRY. Reposting idea only. JUST FOR NEWBIES...
He He.

Waiting for a good announcement from Kanger, BEFORE THE EX-DATE FOR THE RIGHT OR AT LEAST BEFORE THE ACCEPTANCE AND PAYMENT DATE FOR THE RIGHT ISSUE.

If there is any, its can be a catalyst for the price to be pushed up. The current price later should be push up to the higher level to make sure that the RI will be a success.

Take a note that the issue price for the RI share is @ 6 sen per share.>>>>>>>>>>>>>>>>>

United Arab Emirates
The UAE began production of Hayat-Vax, a locally manufactured version of China’s Sinopharm vaccine, in March 2021. Current plans include the production of 2 million doses per month, a majority of which will be exported to low-income countries, particularly Africa and the Middle East, under the WHO’s COVAX scheme.[47][48] By being produced in the UAE, Hayat-Vax is believed to be able to “resolve many of the issues plaguing public acceptance of other vaccines” in Middle Eastern countries.[49]

Solution Biologics is the product registration holder for CanSino in Malaysia.
-------------

If Solution Biologics can own the product registration holder for Covid-19 vaccine, Kanger also can be approved with Hayat-Vax vaccine product registration holder.

------------------

"The Hayat-Vax vaccine is essentially the same Sinopharm Covid-19 vaccine, manufactured in the UAE. Hence, we are confident that it will be well-received and accepted by the Malaysian people as an effective vaccine towards the global fight against the Covid-19 pandemic," said Kuah.

Kanger has also been authorised by G42 to be the product registration holder and distributor of the Hayat-Vax vaccine in Malaysia.

On behalf of G42 Medications, Kanger said it had submitted applications to obtain the required approvals from the National Pharmaceutical Regulatory Agency for the Hayat-Vax vaccine to be used in Malaysia.

Hope the time will come. Sooner or later.

18KHarmoni Kerja operator and promoter is keeping update the RECYLCLE information
-------------
Oh yeah.. Yes, It's a CON counter. It's a CONSTRUCTION RELATED counter. He He

@whistlebower99.

Kanger is still in progressing state in its current businesses, which are a bamboo flooring and related products, and Kanger also in its plan to venture in other business activities such as been involved in the construction services, in a process to acquire property for investment and in a final process to acquire a company which involved in a construction material trading.

All sort of the new investments in the new businesses has expanded via internally generated funds or by the issuance of new shares in Kanger. Its not involved any major debt financing facilities and it’s a ZERO RISKS FINANCING exercises . Therefore the company can minimize the risks of higher debt burden by the company in the future. The financing facility via issuance of new shares also could minimize the cost of financing for the company.

If the new businesses are truly have good potential to improve the revenue and profitability of the company